<DOC>
	<DOC>NCT00980707</DOC>
	<brief_summary>The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.</brief_summary>
	<brief_title>Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma</brief_title>
	<detailed_description>We will compare spirometry, eNO and sputum measurements of versican and hyaluronan before and after treatment with fluticasone 220 ug/bid.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Allergic asthma defined as a positive methacholine challenge Nonatopic patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>versican</keyword>
	<keyword>hyaluronan</keyword>
	<keyword>sputum</keyword>
</DOC>